Hair transplantation in the surgical treatment of central centrifugal cicatricial alopecia.
Abstract
[BACKGROUND] Central centrifugal cicatricial alopecia (CCCA) is a progressive primary scarring alopecia that occurs mainly on the vertex of the scalp and expands centrifugally. To date, there is a paucity of published prospective studies reporting successful surgical therapy for CCCA.
[OBJECTIVE] To evaluate the efficacy of hair transplantation using the round (punch) grafting technique in African American women with CCCA.
[MATERIALS AND METHODS] We describe 2 African American female patients with CCCA who had endured nearly 5 to 6 years of progressive hair loss on the crown of the scalp. After a scalp biopsy and hair transplant test session, both patients underwent hair transplantation with the use of round grafts. Digital photographs were obtained before and after hair transplantation to determine the hair growth success and response rates.
[RESULTS] Hair growth was visibly observed at the recipient sites in both patients beginning between 4 to 5 months post-test session. No postoperative scarring in the recipient or donor areas of the scalp were noted in either patient.
[CONCLUSION] Hair transplantation is a safe well-tolerated procedure to improve hair loss in African American women with end-stage CCCA who histologically display a lack of inflammation on scalp biopsy.
[OBJECTIVE] To evaluate the efficacy of hair transplantation using the round (punch) grafting technique in African American women with CCCA.
[MATERIALS AND METHODS] We describe 2 African American female patients with CCCA who had endured nearly 5 to 6 years of progressive hair loss on the crown of the scalp. After a scalp biopsy and hair transplant test session, both patients underwent hair transplantation with the use of round grafts. Digital photographs were obtained before and after hair transplantation to determine the hair growth success and response rates.
[RESULTS] Hair growth was visibly observed at the recipient sites in both patients beginning between 4 to 5 months post-test session. No postoperative scarring in the recipient or donor areas of the scalp were noted in either patient.
[CONCLUSION] Hair transplantation is a safe well-tolerated procedure to improve hair loss in African American women with end-stage CCCA who histologically display a lack of inflammation on scalp biopsy.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | hair transplantation
|
모발이식 | dict | 5 | |
| 시술 | hair transplant
|
모발이식 | dict | 1 | |
| 해부 | hair
|
scispacy | 1 | ||
| 해부 | grafts
|
scispacy | 1 | ||
| 해부 | scalp
|
scispacy | 1 | ||
| 합병증 | alopecia
|
scispacy | 1 | ||
| 합병증 | scalp
|
scispacy | 1 | ||
| 합병증 | scalp biopsy
|
scispacy | 1 | ||
| 약물 | [BACKGROUND] Central centrifugal cicatricial alopecia
|
scispacy | 1 | ||
| 약물 | [OBJECTIVE]
|
scispacy | 1 | ||
| 약물 | [RESULTS] Hair
|
scispacy | 1 | ||
| 약물 | [CONCLUSION] Hair
|
scispacy | 1 | ||
| 질환 | alopecia
|
C0002170
Alopecia
|
scispacy | 1 | |
| 질환 | primary scarring alopecia
|
scispacy | 1 | ||
| 질환 | hair loss
|
C0002170
Alopecia
|
scispacy | 1 | |
| 질환 | inflammation
|
C0021368
Inflammation
|
scispacy | 1 | |
| 기타 | Hair
|
scispacy | 1 | ||
| 기타 | women
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | patient
|
scispacy | 1 |
MeSH Terms
Adult; Black or African American; Alopecia; Cicatrix; Female; Hair; Humans; Middle Aged; Prospective Studies; Scalp Dermatoses; Treatment Outcome
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- A prospective study of hair transplantation combined with concentrated growth factors for the treatment of androgenetic alopecia.
- Implications of Dermatologic Disorders in Facial Cosmetic Surgery: A Systematic Review.
- Ergonomics in Hair Transplantation: Can Technology Prevent Surgeons From Shortening Their Careers?
- Response to Tringali "Toward Standardized Density Planning in Temporal Triangular Alopecia Treated With ICV-Guided FUE".
- Toward Standardized Density Planning in Temporal Triangular Alopecia Treated With ICV-Guided FUE.